Abdelhamed W, Shousha H, El-Kassas M
Liver Res. 2025; 8(3):141-151.
PMID: 39957750
PMC: 11771265.
DOI: 10.1016/j.livres.2024.09.002.
Shan R, Pei C, Fan Q, Liu J, Wang D, Yang S
BMC Cancer. 2025; 25(1):154.
PMID: 39871149
PMC: 11773783.
DOI: 10.1186/s12885-025-13529-x.
Yan M, Li Z, Claasen M, Santiago A, Rajendran L, Munoz-Schuffenegger P
Ann Surg Oncol. 2024; 32(3):1771-1783.
PMID: 39692983
DOI: 10.1245/s10434-024-16456-6.
Xu W, Li B, Gong H, Li J, Yang Z, Liu Y
Eur J Med Res. 2024; 29(1):518.
PMID: 39465438
PMC: 11514854.
DOI: 10.1186/s40001-024-02116-8.
Pham A, Duc Vu T, Nguyen T, Truong C, Pham A, Vu T
Ann Med Surg (Lond). 2024; 86(6):3667-3673.
PMID: 38846841
PMC: 11152809.
DOI: 10.1097/MS9.0000000000002035.
CEUS in prediction of early recurrence of hepatocellular carcinoma after curative resection and to stratify the risk of early recurrence: a retrospective observational study.
Huang Z, Zhu R, Li S, Luo H, Li K
Abdom Radiol (NY). 2024; 49(6):1870-1880.
PMID: 38557770
DOI: 10.1007/s00261-024-04252-5.
Chemoembolization as first-line treatment for hepatocellular carcinoma invading segmental portal vein with tumour burden limited to a monosegmental level.
Hwang H, Kim J, Ko E, Kim J, Ko H, Gwon D
Br J Radiol. 2024; 97(1157):1038-1043.
PMID: 38445658
PMC: 11075972.
DOI: 10.1093/bjr/tqae052.
Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombus-Related Symptomatic Portal Hypertension.
Xie Y, Lyu T, Song L, Tong X, Wang J, Zou Y
J Clin Exp Hepatol. 2023; 14(2):101305.
PMID: 38130294
PMC: 10733097.
DOI: 10.1016/j.jceh.2023.101305.
2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations.
Kumar A, Acharya S, Singh S, Duseja A, Madan K, Shukla A
J Clin Exp Hepatol. 2023; 14(1):101269.
PMID: 38107186
PMC: 10724697.
DOI: 10.1016/j.jceh.2023.08.005.
Clinical efficacy of HAIC (FOLFOX) combined with lenvatinib plus PD-1 inhibitors vs. TACE combined with lenvatinib plus PD-1 inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulas.
Lin Z, Chen D, Hu X, Huang D, Chen Y, Zhang J
Am J Cancer Res. 2023; 13(11):5455-5465.
PMID: 38058801
PMC: 10695793.
Reappraisal of Portal Vein Tumor Thrombosis as a Prognostic Factor for Patients with Hepatocellular Carcinoma.
Chang Y, Yu S, Kim H, Lee Y, Cho E, Lee J
Gut Liver. 2023; 18(1):156-164.
PMID: 38013475
PMC: 10791491.
DOI: 10.5009/gnl230057.
Hepatocellular Carcinoma in Non-Fibrotic Liver: A Narrative Review.
Naganuma H, Ishida H
Diagnostics (Basel). 2023; 13(22).
PMID: 37998562
PMC: 10670297.
DOI: 10.3390/diagnostics13223426.
The Role of Contrast-Enhanced Ultrasound (CEUS) in the Detection of Neoplastic Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma.
Cerrito L, Ainora M, Di Francesco S, Galasso L, Gasbarrini A, Zocco M
Tomography. 2023; 9(5):1976-1986.
PMID: 37888746
PMC: 10610687.
DOI: 10.3390/tomography9050154.
A Call To Action: Cholangiocarcinoma in the Setting of Sustained Hepatitis C Virologic Response - Case Report and Review of Literature.
Shaik M, Shaik N, Bilgrami Z, Wheeler E, Chow R
J Community Hosp Intern Med Perspect. 2023; 13(4):35-41.
PMID: 37868248
PMC: 10589012.
DOI: 10.55729/2000-9666.1198.
Multidisciplinary Taiwan consensus for the use of conventional TACE in hepatocellular carcinoma treatment.
Chang P, Lee R, Liang P, Liu Y, Chuang V, Wu D
Front Oncol. 2023; 13:1186674.
PMID: 37427137
PMC: 10328116.
DOI: 10.3389/fonc.2023.1186674.
Liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis.
Kim S, Kim J
J Liver Cancer. 2023; 21(2):105-112.
PMID: 37383081
PMC: 10035684.
DOI: 10.17998/jlc.2021.03.17.
Combined Transarterial Chemoembolization and External Beam Radiotherapy in a Patient with Recurrent Huge Hepatocellular Carcinoma after Hepatic Resection.
Yu J, Jung J, Yoon S
J Liver Cancer. 2023; 20(1):90-97.
PMID: 37383057
PMC: 10035695.
DOI: 10.17998/jlc.20.1.90.
Efficacy of Liver-Directed Combined Radiotherapy in Locally Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis.
Kim J, Cheng J, Nam T, Kim J, Jang B, Huang W
Cancers (Basel). 2023; 15(12).
PMID: 37370774
PMC: 10296128.
DOI: 10.3390/cancers15123164.
Two cases of hepatocellular carcinoma successfully treated by carbon ion radiotherapy after atezolizumab plus bevacizumab treatment.
Takakusagi S, Tanaka H, Naganuma A, Kakizaki S, Shibuya K, Ohno T
Clin J Gastroenterol. 2023; 16(3):407-415.
PMID: 36750524
DOI: 10.1007/s12328-023-01768-z.
Perioperative factors related to the prognosis of elderly patients with hepatocellular carcinoma.
Xu L, Xu Y, Li G, Yang B
Eur J Med Res. 2022; 27(1):280.
PMID: 36494837
PMC: 9733384.
DOI: 10.1186/s40001-022-00896-5.